Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
In Sun Goak, Jin A Lee, Min Ho Jeong, Seol Ju Moon & Min Gul Kim. (2022) Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects. Drug Design, Development and Therapy 16, pages 4439-4448.
Read now
Read now
Stewart B. Harris. (2016) The power of two: an update on fixed-dose combinations for type 2 diabetes. Expert Review of Clinical Pharmacology 9:11, pages 1453-1462.
Read now
Read now
Ju-Hee Oh, Ji Eun Lee, Yu Jeong Kim, Tack-Oon Oh, SungKyun Han, Eun Kyung Jeon, Kyungmin Shin, Dong-Hyun Kim, Chi Hye Park & Young-Joo Lee. (2016) Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin. Drug Development and Industrial Pharmacy 42:2, pages 340-349.
Read now
Read now
Stuart A. Ross & Jane Ballantine. (2013) Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes. Current Medical Research and Opinion 29:12, pages 1617-1626.
Read now
Read now
Areana Diogo Nascimento, Lucia Alves Silva Lara, Ana Carolina Japur de Sá Rosa-e-Silva, Rui Alberto Ferriani & Rosana Maria Reis. (2013) Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. Gynecological Endocrinology 29:3, pages 246-249.
Read now
Read now
Serge Jabbour & Barry Ziring. (2011) Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus. Postgraduate Medicine 123:1, pages 15-23.
Read now
Read now
Hermes Florez, Jiacong Luo, Sumaya Castillo-Florez, Georgia Mitsi, John Hanna, Leonardo Tamariz, Ana Palacio, Sukumar Nagendran & Michael Hagan. (2010) Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes. Postgraduate Medicine 122:2, pages 112-120.
Read now
Read now
N Papanas, E Maltezos & DP Mikhailidis. (2009) Metformin: diamonds are forever. Expert Opinion on Pharmacotherapy 10:15, pages 2395-2397.
Read now
Read now
Articles from other publishers (81)
Hannah Syed. (2023) Type 2 diabetes: treatment recommendations for reducing the risk of complications. Nursing Standard 38:7, pages 45-50.
Crossref
Crossref
Reza Noei Razliqi, Akram Ahangarpour, Seyyed Ali Mard & Layasadat Khorsandi. (2023) Gentisic acid ameliorates type 2 diabetes induced by Nicotinamide-Streptozotocin in male mice by attenuating pancreatic oxidative stress and inflammation through modulation of Nrf2 and NF-кB pathways. Life Sciences 325, pages 121770.
Crossref
Crossref
Manoj Chawla, Purvi Chawla, Pratap Jethwani, Kiran Shah & Sanjay Reddy. (2023) Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports. Clinics and Practice 13:2, pages 497-504.
Crossref
Crossref
Vandana Raman, Anshu Gupta, Ambika P Ashraf, Emily Breidbart, Evgenia Gourgari, Manmohan Kamboj, Brenda Kohn, Sowmya Krishnan, Amit Lahoti, Kristal Matlock, Shilpa Mehta, Sejal Mistry, Ryan Miller, Laura Page, Danielle Reynolds & Joan C Han. (2022) Pharmacologic Weight Management in the Era of Adolescent Obesity. The Journal of Clinical Endocrinology & Metabolism 107:10, pages 2716-2728.
Crossref
Crossref
Sijia Wu, Yina He, Yutong Wu, Yiman Ji, Lei Hou, Xinhui Liu, Yilei Ge, Yuanyuan Yu, Yifan Yu, Yun Wei, Fengtong Qian, Qingxin Luo, Yue Feng, Yiping Feng, Jiongjiong Wang, Meiling Huo, Hongkai Li, Fuzhong Xue & Yunxia Liu. (2022) Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis. Frontiers in Endocrinology 13.
Crossref
Crossref
Dong Han Won, Heejun Park, Jeong-Woong Seo, Sun Woo Jang, Eun-Sol Ha & Min-Soo Kim. (2022) Active coating of immediate-release evogliptin tartrate to prepare fixed dose combination tablet with sustained-release metformin HCl. International Journal of Pharmaceutics 623, pages 121927.
Crossref
Crossref
A. Yu. Babenko. (2022) Metformin in prediabetes: key mechanisms for the prevention of diabetes and cardiometabolic risks. Meditsinskiy sovet = Medical Council:10, pages 96-103.
Crossref
Crossref
Sara I. Abd-El Hafeez, Nermin E. Eleraky, Ehsan Hafez & Sara A. Abouelmagd. (2022) Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers. Scientific Reports 12:1.
Crossref
Crossref
Bart J. Kramers, Iris W. Koorevaar, Maatje D.A. van Gastel, Harry van Goor, Kenneth R. Hallows, Hiddo L. Heerspink, Hui Li, Wouter N. Leonhard, Dorien J.M. Peters, Jiedong Qiu, Daan J. Touw, Ron T. Gansevoort & Esther Meijer. (2022) Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD. Clinical Journal of the American Society of Nephrology 17:4, pages 507-517.
Crossref
Crossref
Godela M. Brosnahan, Wei Wang, Berenice Gitomer, Taylor Struemph, Diana George, Zhiying You, Kristen L. Nowak, Jelena Klawitter & Michel B. Chonchol. (2022) Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study. American Journal of Kidney Diseases 79:4, pages 518-526.
Crossref
Crossref
Layla A. Abushamat & Jane E.B. Reusch. (2021) Evolving Concepts of Type 2 Diabetes Management. Medical Clinics of North America 105:6, pages 955-966.
Crossref
Crossref
Erica Wilson. (2021) Person-Centered Medication Therapy for Diabetes in Older Adults: A Practical Review. Journal of Gerontological Nursing 47:10, pages 7-13.
Crossref
Crossref
Li-xin Guo, Guo-en Liu, Li Chen, Hai-fang Wang, Jian Guo, Xian-ling Zheng, Bin-hong Duan, De-zhong Wang, Wei Zhu, Kun Wang, Wan-shou Tan, Qiu Chen, Quan-zhong Li, Jing Yang, Qiu Zhang, Pei-feng Xie & Min-xiang Lei. (2021) Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus. Frontiers in Endocrinology 12.
Crossref
Crossref
Dong Han Won, Heejun Park, Eun-Sol Ha, Hwan-Ho Kim, Sun Woo Jang & Min-Soo Kim. (2021) Optimization of bilayer tablet manufacturing process for fixed dose combination of sustained release high-dose drug and immediate release low-dose drug based on quality by design (QbD). International Journal of Pharmaceutics 605, pages 120838.
Crossref
Crossref
Isabella Panfoli, Alessandra Puddu, Nadia Bertola, Silvia Ravera & Davide Maggi. (2021) The Hormetic Effect of Metformin: “Less Is More”?. International Journal of Molecular Sciences 22:12, pages 6297.
Crossref
Crossref
Jixue Tan, Yang Wang, Song Liu, Qingyang Shi, Xu Zhou, Yiling Zhou, Xiaoling Yang, Pingshan Chen & Sheyu Li. (2021) Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Sameer Joshi, Rajnish Sahu, Vida A. Dennis & Shree R. Singh. (2021) Nanofiller-Enhanced Soft Non-Gelatin Alginate Capsules for Modified Drug Delivery. Pharmaceuticals 14:4, pages 355.
Crossref
Crossref
Laura Elizabeth Satterwhite. (2021) Metformin Extended-Release Oral Solution. Clinical Diabetes 39:2, pages 226-227.
Crossref
Crossref
Marjan Tabesh, Mariam Hachem, Lik-Hui Lau, Karen Borschmann, Leonid Churilov, Sarah A.L. Price, Priya Sumithran, Geoffrey Donnan, Jeffrey Zajac, Vincent Thijs & Elif I. Ekinci. (2021) Feasibility trial of metformin XR in people with pre-diabetes and stroke (MIPPS)-randomised open blinded endpoint controlled trial. Journal of Clinical Neuroscience 86, pages 103-109.
Crossref
Crossref
Abby G. Meyers, Jennifer Hudson, Celeste K. L. Cravalho, Samantha T. Matta, Alfredo Villalobos‐Perez, Fran Cogen & Stephanie T. Chung. (2020) Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center. Pediatric Diabetes 22:2, pages 182-191.
Crossref
Crossref
Jianxin Li, Jing Li, Zhongyan Shan, Wenying Yang, Jie Liu, Haoming Tian, Zhiguang Zhou, Qiuhe Ji, Jianping Weng, Weiping Jia, Juming Lu, Jing Liu, Yuan Xu & Zhaojun Yang. (2021) Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trial. Endocrine Journal 68:1, pages 69-79.
Crossref
Crossref
Ronald Goldenberg, Alan Bell, Willoon Cheng, Nadège Fils-Aimé, Melonie Burrows, Jessica Blavignac, Emilia Parron & Maxime Barakat. (2020) Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care – Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results. Diabetes Research and Clinical Practice 170, pages 108416.
Crossref
Crossref
Ondřej Tesař, Veronika Měrková, Martin Doseděl & Josef Malý. (2020) Food as an important part of maximizing the effect and minimizing the risks of pharmacotherapy - absorption and gastrointestinal tolerance. Klinická farmakologie a farmacie 34:3, pages 108-115.
Crossref
Crossref
Xufei Bian, Lan Jiang, Jing Zhou, Xiaoshu Guan, Jingyu Wang, Peng Xiang, Junyi Pan & Xiangnan Hu. (2020) Improving Dissolution and Cytotoxicity by Forming Multidrug Crystals. Molecules 25:6, pages 1343.
Crossref
Crossref
Noura T. Shurrab & El-Shaimaa A. Arafa. (2020) Metformin: A review of its therapeutic efficacy and adverse effects. Obesity Medicine 17, pages 100186.
Crossref
Crossref
Muhammad S. Akhter & Priyasha Uppal. (2020) Toxicity of Metformin and Hypoglycemic Therapies. Advances in Chronic Kidney Disease 27:1, pages 18-30.
Crossref
Crossref
V. V. Salukhov & B. V. Romashevsky. (2019) Modern aspects for preventive therapy of type 2 diabetes mellitus. Medical Council:4, pages 6-13.
Crossref
Crossref
Jia Min Liau. (2019) Diabetes medication therapy management: have you considered a home medicines review for your patients?. Journal of Pharmacy Practice and Research 49:4, pages 385-388.
Crossref
Crossref
Elena A. Christofides. (2019) Practical Insights Into Improving Adherence to Metformin Therapy in Patients With Type 2 Diabetes. Clinical Diabetes 37:3, pages 234-241.
Crossref
Crossref
Sun-Young Kim, Ji-Young Jeon, Shin Jung Park & Min-Gul Kim. (2019) Pharmacokinetics of a Lobeglitazone/Metformin Fixed-Dose Combination Tablet (CKD-395 0.5/1000 mg) Versus Concomitant Administration of Single Agents and the Effect of Food on the Metabolism of CKD-395 in Healthy Male Subjects. Clinical Pharmacology in Drug Development 8:5, pages 576-584.
Crossref
Crossref
Zeeshan Javed, Maria Papageorgiou, Harshal Deshmukh, Alan S. Rigby, Unaiza Qamar, Jehangir Abbas, Amer Y. Khan, Eric S. Kilpatrick, Stephen L. Atkin & Thozhukat Sathyapalan. (2019) Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study. Clinical Endocrinology 90:6, pages 805-813.
Crossref
Crossref
Lawrence Blonde, Susana Dipp & Daniel Cadena. (2018) Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations. Advances in Therapy 35:7, pages 939-965.
Crossref
Crossref
Mattia Barbot, Filippo Ceccato & Carla Scaroni. (2018) Diabetes Mellitus Secondary to Cushing’s Disease. Frontiers in Endocrinology 9.
Crossref
Crossref
Linong Ji, Jing Liu, Jing Yang, Yufeng Li, Li Liang, Dalong Zhu, Quanmin Li, Tianrong Ma, Haiyan Xu, Yanlan Yang, Jiaoe Zeng, Bo Feng, Shen Qu, Yiming Li, Lizhen Ma, Shanshan Lin, Jianping Wang, Wei Li, Weihong Song, Xiaoxing Li, Yong Luo, Shugang Xi, Mei Lin, Yu Liu & Zerong Liang. (2018) Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial. Diabetes, Obesity and Metabolism 20:4, pages 1006-1013.
Crossref
Crossref
Lorraine Lipscombe, Gillian Booth, Sonia Butalia, Kaberi Dasgupta, Dean T. Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R. Shah & Scot Simpson. (2018) Pharmacologic Glycemic Management of Type 2 Diabetes in Adults. Canadian Journal of Diabetes 42, pages S88-S103.
Crossref
Crossref
Alexander Aliper, Leslie Jellen, Franco Cortese, Artem Artemov, Darla Karpinsky-Semper, Alexey Moskalev, Andrew G. Swick & Alex Zhavoronkov. (2017) Towards natural mimetics of metformin and rapamycin. Aging 9:11, pages 2245-2268.
Crossref
Crossref
Clifford J. Bailey. (2017) Metformin: historical overview. Diabetologia 60:9, pages 1566-1576.
Crossref
Crossref
Fabrice Bonnet & André Scheen. (2017) Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, Obesity and Metabolism 19:4, pages 473-481.
Crossref
Crossref
George Grunberger. (2017) Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?. Current Diabetes Reports 17:4.
Crossref
Crossref
Andrew J. Krentz & Alan J. Sinclair. 2017. Diabetes in Old Age. Diabetes in Old Age
298
322
.
Huang-tz Ou, Pei-Chi Chen & Meng-Hsing Wu. (2017) Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome. Journal of the Formosan Medical Association 116:2, pages 80-89.
Crossref
Crossref
Rhona Johnston, Olalekan Uthman, Ewen Cummins, Christine Clar, Pamela Royle, Jill Colquitt, Bee Kang Tan, Andrew Clegg, Saran Shantikumar, Rachel Court, J Paul O’Hare, David McGrane, Tim Holt & Norman Waugh. (2017) Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation. Health Technology Assessment 21:2, pages 1-218.
Crossref
Crossref
Yoshihito Fujita & Nobuya Inagaki. (2017) Metformin: New Preparations and Nonglycemic Benefits. Current Diabetes Reports 17:1.
Crossref
Crossref
G. Verstraete, P. Mertens, W. Grymonpré, P.J. Van Bockstal, T. De Beer, M.N. Boone, L. Van Hoorebeke, J.P. Remon & C. Vervaet. (2016) A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices. International Journal of Pharmaceutics 513:1-2, pages 602-611.
Crossref
Crossref
M P van der Aa, M A J Elst, E M W van de Garde, E G A H van Mil, C A J Knibbe & M M J van der Vorst. (2016) Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial. Nutrition & Diabetes 6:8, pages e228-e228.
Crossref
Crossref
An-Katrien Vynckier, Jody Voorspoels, Jean Paul Remon & Chris Vervaet. (2016) Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product. Journal of Pharmacy and Pharmacology 68:5, pages 721-727.
Crossref
Crossref
Timothy J. Church & Stuart T. Haines. (2016) Treatment Approach to Patients With Severe Insulin Resistance. Clinical Diabetes 34:2, pages 97-104.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
969
983
.
Michael Mendoza & Colleen Loo-Gross. 2016. Men's Health in Primary Care. Men's Health in Primary Care
125
143
.
Linda Tran, Angela Zielinski, Arpi H. Roach, Jennifer A. Jende, Ann Marie Householder, Emily E. Cole, Shuruq A. Atway, Melinda Amornyard, Mallory L. Accursi, Suzanna W. Shieh & Erin E. Thompson. (2015) Pharmacologic Treatment of Type 2 Diabetes. Annals of Pharmacotherapy 49:5, pages 540-556.
Crossref
Crossref
Linong Ji, Bernard Zinman, Sanjay Patel, Jinfeng Ji, Zelie Bailes, Sandra Thiemann & Thomas Seck. (2015) Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial. Advances in Therapy 32:3, pages 201-215.
Crossref
Crossref
Lawrence Blonde, Zinnia T. San Juan & Peggy Bolton. (2014) Fixed-Dose Combination Therapy in Type 2 Diabetes Mellitus. Endocrine Practice 20:12, pages 1322-1332.
Crossref
Crossref
Antonio R. Chacra. (2014) Evolving Metformin Treatment Strategies in Type-2 Diabetes. American Journal of Therapeutics 21:3, pages 198-210.
Crossref
Crossref
Avinash G. Thombre, Alfred Berchielli & Janyce F. Rogers. (2014) Extemporaneously prepared controlled release formulations for accelerating the early phase development of drug candidates. Drug Discovery Today 19:5, pages 694-700.
Crossref
Crossref
S. V Kakorin, I. A Averkova & A. M Mkrtumyan. (2014) Hypoglycemic therapy in patients with type 2 diabetes and chronic heart failure. CardioSomatics 5:1, pages 33-40.
Crossref
Crossref
Brian J. Gates & Kevin M. Walker. (2014) Physiological Changes in Older Adults and Their Effect on Diabetes Treatment. Diabetes Spectrum 27:1, pages 20-29.
Crossref
Crossref
Peter Timmins, Samuel R. Pygall & Colin D. Melia. 2014. Hydrophilic Matrix Tablets for Oral Controlled Release. Hydrophilic Matrix Tablets for Oral Controlled Release
1
15
.
Y.-C. Hwang, M. Kang, C. W. Ahn, J. S. Park, S. H. Baik, D. J. Chung, H. C. Jang, K.-A. Kim, I.-K. Lee, K. W. Min, M. Nam, T. S. Park, S. M. Son, Y.-A. Sung, J.-T. Woo, K. S. Park & M.-K. Lee. (2013) Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes. International Journal of Clinical Practice 67:3, pages 236-243.
Crossref
Crossref
Linong Ji, Hongmei Li, Xiaohui Guo, Yan Li, Renming Hu & Zhengying Zhu. (2013) Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial. PLoS ONE 8:2, pages e57222.
Crossref
Crossref
Chul‐Hee Kim, Kyung‐Ah Han, Han‐Jin Oh, Kevin Eng‐Kiat Tan, Radhakrishna Sothiratnam, Askandar Tjokroprawiro & Marcus Klein. (2012) Safety, tolerability, and efficacy of metformin extended‐release oral antidiabetic therapy in patients with type 2 diabetes: An observational trial in Asia. Journal of Diabetes 4:4, pages 395-406.
Crossref
Crossref
G. Wright BatesJr.Jr. & Anthony M. Propst. (2012) Polycystic Ovarian Syndrome Management Options. Obstetrics and Gynecology Clinics of North America 39:4, pages 495-506.
Crossref
Crossref
. (2011) Russian Association of Endocrinologists reports commencement of Glucophage XR clinical use. Diabetes mellitus 14:4, pages 124-124.
Crossref
Crossref
Liana Hakobyan, Flora M. Haaijer-Ruskamp, Dick de Zeeuw, Daniela Dobre & Petra Denig. (2011) Comparing Adverse Event Rates of Oral Blood Glucose-Lowering Drugs Reported by Patients and Healthcare Providers. Drug Safety 34:12, pages 1191-1202.
Crossref
Crossref
Liana Hakobyan, Flora M Haaijer-Ruskamp, Dick de Zeeuw, Daniela Dobre & Petra Denig. (2011) A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients. Health and Quality of Life Outcomes 9:1.
Crossref
Crossref
Mahasen A Radwan, Esraa S Al Taweel, Abdulrahman M Al-Moghairi, Nouf M Aloudah, Muneera A Al Babtain & Hussein S Al-Amri. (2011) Monitoring Metformin in Cardiac Patients Exposed to Contrast Media Using Ultra–High-Performance Liquid Chromatography Tandem Mass-Spectrometry. Therapeutic Drug Monitoring 33:6, pages 742-749.
Crossref
Crossref
Juliana Levy, Roberta A Cobas & Marília B Gomes. (2010) Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 2:1.
Crossref
Crossref
Rajeev Jain & Dwain L. Thiele. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
557
592.e11
.
Kristiina M. Huttunen, Anne Mannila, Krista Laine, Eeva Kemppainen, Jukka Leppänen, Jouko Vepsäläinen, Tomi Järvinen & Jarkko Rautio. (2009) The First Bioreversible Prodrug of Metformin with Improved Lipophilicity and Enhanced Intestinal Absorption. Journal of Medicinal Chemistry 52:14, pages 4142-4148.
Crossref
Crossref
Alex J KentBethan Graf, Priyajit Prasad, Matthew R Banks & Michael D Feher. (2009) Diabetes treatments, gastrointestinal symptoms and lower gastrointestinal endoscopy. The British Journal of Diabetes & Vascular Disease 9:3, pages 129-130.
Crossref
Crossref
L. A. Donnelly, A. D. Morris & E. R. Pearson. (2009) Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes, Obesity and Metabolism 11:4, pages 338-342.
Crossref
Crossref
N. PapanasE. Maltezos. (2009) Metformin: A Review of Its Use in the Treatment of Type 2 Diabetes. Clinical Medicine. Therapeutics 1, pages CMT.S1085.
Crossref
Crossref
. 2009. Meyler's Side Effects of Endocrine and Metabolic Drugs. Meyler's Side Effects of Endocrine and Metabolic Drugs
357
473
.
John HB Scarpello & Harry CS Howlett. (2008) Metformin therapy and clinical uses. Diabetes and Vascular Disease Research 5:3, pages 157-167.
Crossref
Crossref
H. Gao, W. Xiao, C. Wang, J. Zhang, Y. Yang, J. Yang, W. Yang & T. Hong. (2008) The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study. International Journal of Clinical Practice 62:5, pages 695-700.
Crossref
Crossref
Michael D FeherMa'en Al-Mrayat, Julie Brake & King Sun Leong. (2016) Tolerability of prolonged-release metformin (Glucophage® SR) in individuals intolerant to standard metformin — results from four UK centres. The British Journal of Diabetes & Vascular Disease 7:5, pages 225-228.
Crossref
Crossref
Louis S. Matza, Kristina S. Boye, Nicole Yurgin, Jessica Brewster-Jordan, Sally Mannix, Jodi M. Shorr & Beth L. Barber. (2007) Utilities and disutilities for type 2 diabetes treatment-related attributes. Quality of Life Research 16:7, pages 1251-1265.
Crossref
Crossref
R.C.L. Page. 2007.
523
538
.
Thomas W. Donner. (2006) Tight control of hyperglycemia in type 2 diabetes mellitus. Insulin 1:4, pages 166-172.
Crossref
Crossref
Mike Kirby. (2005) Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy. International Journal of Clinical Practice 59:3, pages 263-266.
Crossref
Crossref
A Consoli, R Gomis, S Halimi, PD Home, H Mehnert, K Strojek & LF Van Gaal. (2004) Initiating oral glucose-lowering therapy with metformin in tyape 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes & Metabolism 30:6, pages 509-516.
Crossref
Crossref
Jaime Davidson & Harry Howlett. (2016) New prolonged-release metformin improves gastrointestinal tolerability. The British Journal of Diabetes & Vascular Disease 4:4, pages 273-277.
Crossref
Crossref